Invitae

Excitement in the consumer genetic testing market continues to show signs of slowing down. In the past two weeks, layoffs have hit two of the biggest consumer genetic testing services — 23andme and

Life sciences is big business in venture capital land and firms are raising big dollars to find the companies that will lead the next healthcare revolution. Chief among them is Andreessen Horowitz, wh

Investors have forked over $33 million in a new round of funding for Redox, hoping that the company can execute on its bid to serve as the link between healthcare providers and the technology companie

Genomics has undergone a major shift in the last year. The drop in price in the past decade from $3B to $1K to sequence a genome is the 10X force likely to cause an inflection point in a number of hea